Iron Horse to raise up to $10 mln Series A
Avalon Ventures and GlaxoSmithKline have launched Iron Horse Therapeutics, which will receive up to $10 million in Series A funding. The seventh company to be formed by the Avalon/GSK partnership, Iron Horse is focused on developing new treatments for ALS.
9 November 2015•3 mins read
